US Patent Issued to Shandong Boan Biotechnology on May 27 for "Antibody or chimeric antigen receptor which targets Claudin 18.2" (Chinese, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,402, issued on May 27, was assigned to Shandong Boan Biotechnology Co. Ltd. (Yantai, China).

"Antibody or chimeric antigen receptor which targets Claudin 18.2" was invented by Deyong Song (Shandong, China), Li Zhou (Woburn, Mass.), Chuangchuang Dong (Shandong, China) and Zhenfei Ning (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are an antibody or an antigen binding fragment or chimeric antigen receptor thereof which binds to Claudin18.2, and a preparation method and a use. The chimeric antigen receptor sequentially comprises the antibody or the antigen binding fragment thereof which binds to the Claudin18.2 antigen, an e...